Abstract | BACKGROUND: OBJECTIVE: The aim of the study was to evaluate the efficacy and safety of topical calcipotriol for the treatment of mild-to-moderate patchy AA. METHOD: Forty-eight patients with mild-to-moderate AA were enrolled in the retrospective, 12-week trial. Calcipotriol cream was applied to the affected areas twice a day. Severity of Alopecia Tool ( SALT) score and hair regrowth rate were calculated at baseline and at 3, 6, 9, and 12 weeks. RESULTS: At week 12, the total response was achieved in 69.2% of patients. When the mean SALT score of patients at week 12 was compared to that of patients at baseline, the value at week 12 was significantly lower (P= 0.001). A regrowth score (RGS) ≥ 3 (hair regrowth of ≥ 50%) was observed in 75% of patients, whereas a RGS ≥ 4 (hair regrowth of ≥ 75%) was observed in 62.5% of patients and the complete regrowth rate (hair regrowth= 100%) was 27.1%. CONCLUSION:
Calcipotriol may serve as a safe and effective treatment option in mild-to-moderate patchy AA, and calls for more extensive controlled studies with this treatment.
|
Authors | Aslı Aksu Çerman, Sezgi Sarıkaya Solak, İlknur Altunay, Nihal Aslı Küçükünal |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 14
Issue 6
Pg. 616-20
(Jun 2015)
ISSN: 1545-9616 [Print] United States |
PMID | 26091388
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Immunologic Factors
- calcipotriene
- Calcitriol
|
Topics |
- Administration, Topical
- Adult
- Alopecia Areata
(drug therapy)
- Calcitriol
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Female
- Humans
- Immunologic Factors
(administration & dosage, adverse effects, therapeutic use)
- Male
- Retrospective Studies
- Treatment Outcome
|